A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects

NCT02571855 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: ACT-541468 (hydrochloride salt)
DRUG: ACT-541468 (free base)
DRUG: Placebo

Sponsor

Idorsia Pharmaceuticals Ltd.